Evidence-based·Last reviewed May 30, 2026·How we grade evidence

Bifidobacterium animalis lactis

ProbioticBifidobacterium

Useful mainly for people wanting help with bowel regularity or prevention of antibiotic-associated diarrhea.

Quick decision guide

May help most

people wanting help with bowel regularity or prevention of antibiotic-associated diarrhea

Common dosing range

1–20 billion CFU/day

When to expect effects

2–4 weeks for regularity

Watch out for

Severely immunocompromised or critically ill people face a small bacteremia risk

What is it

Bifidobacterium animalis subsp. lactis is one of the most commonly used probiotic bacteria in commercial yogurts and supplements. It is notable for its robustness, surviving manufacturing, storage, and gastrointestinal transit better than many other Bifidobacterium species.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You want help with constipation or bowel regularity
You are taking antibiotics and want to reduce diarrhea risk
You want a robust, well-studied probiotic species

Probably skip if

You are severely immunocompromised or critically ill (consult a physician)
You expect benefits beyond the specific strain studied
You want a quick fix rather than weeks of consistent use

Evidence at a glance

constipation and bowel regularity

Good Evidence
Effect
Modest improvement in transit and stool frequency
Best fit
adults with constipation or sluggish transit using a studied strain (e.g. DN-173 010, HN019)
Time
2–4 weeks

gut microbiota modulation

Limited Evidence
Effect
Measurable shifts in microbiota composition
Best fit
people wanting to increase Bifidobacteria and short-chain fatty acid production
Time
Weeks

respiratory tract infections

Limited Evidence
Effect
Small reduction in incidence/duration
Best fit
people seeking modest reduction in common respiratory infections (e.g. BL-04)
Time
Weeks of ongoing use

Evidence for 3 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

constipation and bowel regularity

Supplement benefit
Good Evidence

Randomized trials of specific B. animalis subsp. lactis strains report improved colonic transit time and stool frequency. Benefits are strain-specific, so results from one strain do not guarantee another performs the same.

Effect size
Modest improvement in transit and stool frequency
Time to effect
2–4 weeks
Best fit
adults with constipation or sluggish transit using a studied strain (e.g. DN-173 010, HN019)

Bottom line: Certain B. lactis strains modestly improve bowel regularity over a few weeks.

gut microbiota modulation

Biomarker support
Limited Evidence

B. animalis subsp. lactis transiently increases Bifidobacteria and short-chain fatty acid production, measurably altering the colonic environment. These are microbiota/biomarker changes that do not by themselves prove a clinical benefit.

Effect size
Measurable shifts in microbiota composition
Time to effect
Weeks
Best fit
people wanting to increase Bifidobacteria and short-chain fatty acid production
Less likely
people expecting microbiota changes to guarantee symptom relief

Bottom line: This species reliably shifts gut microbiota markers, though that is not itself a clinical outcome.

respiratory tract infections

Supplement benefit
Limited Evidence

Some trials of specific strains report fewer or shorter respiratory infections, but results are inconsistent across populations and strains. The evidence is preliminary.

Effect size
Small reduction in incidence/duration
Time to effect
Weeks of ongoing use
Best fit
people seeking modest reduction in common respiratory infections (e.g. BL-04)

Bottom line: B. lactis may modestly reduce respiratory infections, but evidence is limited and strain-specific.

Evidence is mixed

Benefit appears in some strain-specific trials but not consistently across studies.

How it works

B. animalis subsp. lactis colonizes the colon transiently, where it ferments dietary fibers and other carbohydrates to produce short-chain fatty acids, primarily acetate. These acidify the colonic environment, support colonocyte energy supply, and create conditions less favorable for many pathogenic bacteria. It interacts with intestinal epithelial cells and the gut-associated immune system, supporting intestinal barrier function and modulating cytokine production. Some strains have been shown to improve transit time, which may underlie observed benefits for constipation and bowel regularity. The species is also notable for its bile salt hydrolase activity, which may influence lipid metabolism. Multiple strains have been extensively studied. BB-12 has the most published research, with applications in digestive health, immune function, and respiratory infections. DN-173 010 (used in some commercial yogurt brands) has been studied for constipation and bowel regularity. HN019 has been studied for digestive function and immunity in older adults. BL-04 has been studied for respiratory health.

How to take it

1. Typical dose
1–20 billion CFU/day (most trials in this range)
2. Timing
Anytime; consistency matters more than timing
3. With food
With or without food; a small meal may aid survival through the stomach
4. How long to try
Allow 2–4 weeks of consistent use for regularity

What to track

stool frequency and consistency
bloating or gas
bowel comfort

4 commercial forms

Compare the main delivery options and what they’re best suited for.

B. animalis subsp. lactis BB-12

Most extensively researched strain in this species. Used in many branded yogurts and supplements globally.

Robust acid and bile tolerance, well-studied

B. animalis subsp. lactis DN-173 010

Used in Activia and similar branded yogurts. Studied for bowel regularity in adults.

Studied for transit and constipation

B. animalis subsp. lactis HN019

Used in adult and senior probiotic formulations targeting immune and digestive function.

Studied for immunity and constipation

B. animalis subsp. lactis BL-04

Used in immune-targeted supplements, often with Lactobacillus strains.

Studied for respiratory applications

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

transient gasbloatingstool changes

Serious risks

  • rare bacteremia in immunocompromised or critically ill people

Who should avoid it

  • severely immunocompromised individuals
  • people with central venous catheters
  • critically ill patients
  • premature infants except under specialist supervision

Pregnancy & breastfeeding

Generally well tolerated in pregnancy and breastfeeding.

Interactions

antibioticsModerate

antibiotics can kill the organisms; separate doses by at least 2 hours

immunosuppressive medicationsModerate

may slightly raise the risk of bacterial translocation

Food sources

Activia yogurt (DN-173 010)

Amount
Approximately 10^9 to 10^10 CFU per serving
%DV

Other commercial yogurts with added BB-12

Amount
Variable; check label for live culture content
%DV

Kefir

Amount
Variable Bifidobacterium content
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

named strain (e.g. BB-12, HN019, DN-173 010)
CFU guaranteed through expiry
storage requirements stated

Be skeptical of

boosts immunity for everyone
cures IBS or any disease
vague 'billions of probiotics' without strain identity

Frequently asked questions

Why is BB-12 the most studied probiotic?

BB-12 was one of the first commercially developed probiotic strains optimized for survival through manufacturing, storage, and digestion. Its long market presence has allowed for extensive research across many applications.

Is Activia yogurt actually effective for digestion?

Trials of B. animalis DN-173 010 (used in Activia) show modest improvements in transit time and bowel regularity. Effects are small but real for many people, particularly those with mild constipation.

How quickly does B. animalis work for constipation?

Trials typically show effects emerging over 2 to 4 weeks of consistent daily use. Effects reverse after stopping supplementation.

Can I take this with other probiotics?

Yes. B. animalis subsp. lactis is commonly combined with Lactobacillus and other Bifidobacterium strains in multi-strain formulations.

Does it need to be refrigerated?

Most B. animalis subsp. lactis supplements maintain potency at room temperature for the shelf life on the label, especially if encapsulated. Refrigeration generally extends viability.

References by claim

constipation and bowel regularity

Cheng et al., 2024PMC (2024) link

Ibarra et al., 2018PMC (2018) link

gut microbiota modulation

Liu et al., 2025PMC (2025) link

respiratory tract infections

Meng et al., 2016PubMed (2016) link

Track Bifidobacterium animalis lactis with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 30, 2026·Evidence current as of May 30, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.